United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
| Key metrics |
|---|
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Cell Source, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Actual |
|---|
| Forecast |
|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|
| ROE | 26.43% | 23.66% | 19.69% | 15.79% | 13.69% | 12.26% |
|---|---|---|---|---|---|---|
| Sector average | -232.63% | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% |
| Total Assets | $286.50K | $211.87K | $211.87K | $211.87K | $211.87K | $211.87K |
| Net Income | -$4,512.64K | -$4,974.09K | -$5,135.02K | -$4,909.57K | -$4,932.18K | -$5,025.91K |